220 related articles for article (PubMed ID: 19015339)
21. Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in Streptococcus pneumoniae.
Li Y; Metcalf BJ; Chochua S; Li Z; Gertz RE; Walker H; Hawkins PA; Tran T; Whitney CG; McGee L; Beall BW
mBio; 2016 Jun; 7(3):. PubMed ID: 27302760
[TBL] [Abstract][Full Text] [Related]
22. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.
Karlowsky JA; Adam HJ; Decorby MR; Lagacé-Wiens PR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2011 Jun; 55(6):2837-46. PubMed ID: 21402844
[TBL] [Abstract][Full Text] [Related]
24. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
[TBL] [Abstract][Full Text] [Related]
26. Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).
Morrissey I; Leakey A
J Antimicrob Chemother; 2012 Jun; 67(6):1408-12. PubMed ID: 22357801
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.
Doern GV; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Richter SS
Antimicrob Agents Chemother; 2012 Jun; 56(6):3406-8. PubMed ID: 22491687
[TBL] [Abstract][Full Text] [Related]
28. Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
Pfaller MA; Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):422-8. PubMed ID: 24445158
[TBL] [Abstract][Full Text] [Related]
29. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Biek D; Critchley IA; Riccobene TA; Thye DA
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
31. Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
Clark C; McGhee P; Appelbaum PC; Kosowska-Shick K
Antimicrob Agents Chemother; 2011 May; 55(5):2344-51. PubMed ID: 21343467
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible
Sader HS; Castanheira M; Carvalhaes CG; Arends SJR; Mendes RE
Microb Drug Resist; 2022 Sep; 28(9):935-940. PubMed ID: 35976086
[TBL] [Abstract][Full Text] [Related]
33.
Pfaller MA; Mendes RE; Duncan LR; Flamm RK; Sader HS
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158271
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood.
Sakata H
J Infect Chemother; 2006 Oct; 12(5):338-42. PubMed ID: 17109098
[TBL] [Abstract][Full Text] [Related]
36. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.
Moisan H; Pruneau M; Malouin F
J Antimicrob Chemother; 2010 Apr; 65(4):713-6. PubMed ID: 20097788
[TBL] [Abstract][Full Text] [Related]
37. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission.
Samore MH; Magill MK; Alder SC; Severina E; Morrison-De Boer L; Lyon JL; Carroll K; Leary J; Stone MB; Bradford D; Reading J; Tomasz A; Sande MA
Pediatrics; 2001 Oct; 108(4):856-65. PubMed ID: 11581436
[TBL] [Abstract][Full Text] [Related]
38. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
Jones RN; Sader HS; Mendes RE; Flamm RK
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):107-9. PubMed ID: 23009730
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.
Morrissey I; Leakey A; Northwood JB
Int J Antimicrob Agents; 2012 Sep; 40(3):227-34. PubMed ID: 22796201
[TBL] [Abstract][Full Text] [Related]
40. Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
Pfaller MA; Mendes RE; Castanheira M; Flamm RK; Jones RN; Sader HS
Pediatr Infect Dis J; 2017 May; 36(5):486-491. PubMed ID: 28403050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
